{"schema_version":"secwatch.filing_event.v1","accession":"0001601830-23-000078","form_type":"8-K","ticker":"RXRX","cik":"0001601830","company_name":"RECURSION PHARMACEUTICALS, INC.","filed_at":"2023-12-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.724263+00:00","generated_at":"2026-06-07T09:50:32.571161+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Recursion partners with Enamine to create enriched screening libraries using MatchMaker predictions on 36B compounds","bullets":["Up to 100 biological targets selected; Recursion's MatchMaker predicts protein-ligand interactions across Enamine's 36B REAL Space compounds.","Recursion will receive significant number of unique REAL compounds at no cost and preferential pricing on enriched libraries.","Enamine may offer resulting libraries to customers; libraries co-branded under Enamine and MatchMaker trademarks.","MatchMaker uses ML for binding predictions, more scalable than traditional docking; expedites wet-lab experiments."],"urls":{"canonical":"https://secwatch.observer/filing/0001601830-23-000078","json":"https://secwatch.observer/filing/0001601830-23-000078.json","markdown":"https://secwatch.observer/filing/0001601830-23-000078.md","text":"https://secwatch.observer/filing/0001601830-23-000078.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1601830/000160183023000078/0001601830-23-000078-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1601830/000160183023000078/rxrx-20231220.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T09:50:32.571161+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}